United States  

“News neutrality by unbiased coverage”
One News Page
Regeneron News 
0
shares
ShareTweetSavePostSend
 

Eylea Competition Coming But Pipeline Could Maintain Growth For Regeneron


SeekingAlpha

Regeneron and Sanofi's Dupixent shows treatment benefit in adolescents with atopic dermatitis


SeekingAlpha

Videos for regeneron

Nasdaq 100 Movers: AMAT, PCAR [Video]Nasdaq 100 Movers: AMAT, PCAR

In early trading on Friday, shares of PACCAR topped the list of the day's best performing components of the Nasdaq 100 index, trading up 1.8%. Year to date, PACCAR has lost about 6.0% of its value.

Market News Video -   01:06

Nasdaq 100 Movers: MYL, QRTEA [Video]Nasdaq 100 Movers: MYL, QRTEA

In early trading on Wednesday, shares of Qurate Retail (QRTEA) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.6%. Year to date, Qurate Retail has lost..

Market News Video -   01:07

 

Autotask relocating in East Greenbush to make way for Regeneron growth

Regeneron needs more office, lab and research space after announcing plans to add 1,500 new jobs and invest $800 million in the region over the next few years.
bizjournals

FDA accepts Regeneron's application for Eylea for diabetic retinopathy, action date May 13, 2019


SeekingAlpha

Molecular Partners Reports Key Financials for H1 18 and Corporate Highlights for the Second Quarter 2018: Promising MP0250 Clinical Data in Oncology and Positive Abicipar Phase 3 Efficacy Data Presented

molecular partners reports key financials for h1 18 and corporate highlights for the second quarter 2018: promising mp0250 clinical data in oncology and positive abicipar phase 3 efficacy data presented
· *Promising initial data from MP0250 combination with bortezomib (Velcade^®) in phase 2 study in multiple myeloma: Five of eight evaluable patients achieved an objective response with median time of..
Accesswire

Will Regeneron Close At $400?


SeekingAlpha

FDA OKs 12-week dosing regimen for Regeneron's Eylea in wet AMD


SeekingAlpha

Regeneron and Teva's fasinumab shows positive effect in late-stage osteoarthritis study


SeekingAlpha

Regeneron: A Buy On Dupixent And Pipeline


SeekingAlpha

FDA rejects Regeneron's application for 12-week dosing of Eylea for wet AMD


SeekingAlpha

Shares in bluebird bio soar after it strikes partnership with Regeneron to work on immune cell therapies

Shares in bluebird bio Inc (NASDAQ:BLUE) climbed in premarket trade Monday after it announced a strategic collaboration with Regeneron Pharmaceuticals (NASDAQ:REGN) to discover, develop and..
Proactive Investors

Regeneron and Bluebird Bio collaborates to discover, develop and commercialize new cell therapies for cancer


SeekingAlpha

Regeneron: How This Bull Can Continue To Gore The Bears


SeekingAlpha

Regeneron Pharmaceuticals (REGN) Q2 2018 Results - Earnings Call Transcript


SeekingAlpha

Regeneron Pharmaceuticals Q2 revenues up 9%; non-GAAP EPS up 31%


SeekingAlpha

Large-cap biotech stocks will just tread water as sector sizzles

Investors betting on a resurgence for large-cap biotech stocks shouldn’t hold their breath. That’s the advice from analysts covering the sector as shares of companies such as Celgene Corp. and..
SFGate

Regeneron's Price Implies Opportunity


SeekingAlpha

Regeneron: The Catalysts


SeekingAlpha

This May Be The Best Time To Buy Regeneron In 2018


SeekingAlpha

Regeneron adds to breakout, up 2%


SeekingAlpha

You Might Like


 Page 1  〉 
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+  •  FOLLOW us on Pinterest